Development of nonaluminum phosphate binder hydrous cerium oxide (Ce alpha (OH)4-2 alpha . nH2O).
D000535:Aluminum / Q000009:adverse effects*; D000818:Animals; D002563:Cerium / Q000627:therapeutic use*; D002614:Chelating Agents; D004285:Dogs; D006801:Humans; D006878:Hydroxides / Q000627:therapeutic use*; D010710:Phosphates / Q000097:blood*
D002614:Chelating Agents; D006878:Hydroxides; D010710:Phosphates; D002563:Cerium; C048873:cerium hydroxide; D000535:Aluminum